Published in Crit Care Med on August 01, 1995
Neurometabolic mechanisms for memory enhancement and neuroprotection of methylene blue. Prog Neurobiol (2011) 1.37
Activation of the L-arginine nitric oxide pathway in severe sepsis. Arch Dis Child (1997) 1.37
sGC(alpha)1(beta)1 attenuates cardiac dysfunction and mortality in murine inflammatory shock models. Am J Physiol Heart Circ Physiol (2009) 1.21
The effects of methylene blue on hemodynamic parameters and cytokine levels in refractory septic shock. Korean J Intern Med (2005) 0.84
Effect of a single bolus of methylene blue prophylaxis on vasopressor and transfusion requirement in infective endocarditis patients undergoing cardiac surgery. Korean J Anesthesiol (2012) 0.82
Continuous infusion of methylene blue for septic shock. Postgrad Med J (1996) 0.81
Cardiovascular and pharmacological implications of haem-deficient NO-unresponsive soluble guanylate cyclase knock-in mice. Nat Commun (2015) 0.78
Methylene blue inhibits angiogenesis in chick chorioallontoic membrane through a nitric oxide-independent mechanism. J Cell Mol Med (2006) 0.77
Systemic capillary leak syndrome: is methylene blue the silver bullet? Case Rep Crit Care (2014) 0.75
Postreperfusion syndrome during liver transplantation. Korean J Anesthesiol (2015) 0.75
Improvement in Hemodynamics After Methylene Blue Administration in Drug-Induced Vasodilatory Shock: A Case Report. J Med Toxicol (2015) 0.75
Role of Methylene Blue in the Maintenance of Postinduction Hemodynamic Status in Patients with Perforation Peritonitis: A Pilot Study. Anesth Essays Res (2017) 0.75
The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med (1996) 35.00
Increased plasma levels of interleukin-6 in sepsis. Blood (1989) 3.92
Nitric oxide: a predictor of morbidity in postoperative patients? Lancet (1994) 3.26
Randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma. Lancet (1998) 2.84
Hypernatremia in the intensive care unit: an indicator of quality of care? Crit Care Med (1999) 2.33
Antithrombin III in patients with severe sepsis. A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsis. Intensive Care Med (1998) 2.12
Comparison of seven immunoassays for the quantification of CA 125 antigen in serum. Clin Chem (1998) 1.90
Interleukin-8 in sepsis: relation to shock and inflammatory mediators. Infect Immun (1992) 1.85
High levels of interleukin 10 and tumor necrosis factor alpha in cerebrospinal fluid during the onset of bacterial meningitis. Clin Infect Dis (1995) 1.70
Ten years of experience in the treatment of gas gangrene with hyperbaric oxygen. Surg Gynecol Obstet (1972) 1.67
Plasma elastase alpha 1-antitrypsin and lactoferrin in sepsis: evidence for neutrophils as mediators in fatal sepsis. J Lab Clin Med (1992) 1.65
Transvascular transport of 67Ga in the lungs after cardiopulmonary bypass surgery. Chest (1993) 1.64
Helicobacter pylori and the birth cohort effect: evidence of a continuous decrease of infection rates in childhood. Am J Gastroenterol (1997) 1.62
C1-esterase inhibitor substitution in sepsis. Lancet (1992) 1.61
Prediction of mortality in febrile medical patients: How useful are systemic inflammatory response syndrome and sepsis criteria? Chest (1998) 1.61
Role of cytokines in sepsis. Adv Immunol (1997) 1.60
Continuous cardiac output in septic shock by simulating a model of the aortic input impedance: a comparison with bolus injection thermodilution. Anesthesiology (1999) 1.57
Memory complaints and APOE-epsilon4 accelerate cognitive decline in cognitively normal elderly. Neurology (2001) 1.57
Phase I therapy study of 186Re-labeled chimeric monoclonal antibody U36 in patients with squamous cell carcinoma of the head and neck. J Nucl Med (2000) 1.52
Outcome of ICU treatment in invasive aspergillosis. Intensive Care Med (1996) 1.52
Antibiotic-induced release of lipoteichoic acid and peptidoglycan from Staphylococcus aureus: quantitative measurements and biological reactivities. Antimicrob Agents Chemother (1998) 1.50
Antithrombin III in patients with severe sepsis: a pharmacokinetic study. Intensive Care Med (2000) 1.49
Acute lung injury after aortic surgery: the relation between lung and leg microvascular permeability to 111indium-labelled transferrin and circulating mediators. Thorax (1997) 1.48
Cardiac tamponade from misplaced central venous line in pericardiophrenic vein. Arch Intern Med (1988) 1.48
Plasma levels of the chemokines monocyte chemotactic proteins-1 and -2 are elevated in human sepsis. Blood (1995) 1.47
Antibodies to components of neutrophil cytoplasm: a new diagnostic tool in patients with Wegener's granulomatosis and systemic vasculitis. Q J Med (1988) 1.47
C1-inhibitor substitution therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2. Intensive Care Med (1993) 1.45
Age, chronic disease, sepsis, organ system failure, and mortality in a medical intensive care unit. Crit Care Med (1990) 1.43
Acute renal failure in the medical intensive care unit: predisposing, complicating factors and outcome. Nephron (1991) 1.41
Predicting outcome after cardiac surgery: comparison of global haemodynamic and tonometric variables. Br J Anaesth (1999) 1.41
Influence of sex hormones on plasma endothelin levels. Ann Intern Med (1993) 1.40
[The many faces of the acid-fast rod]. Ned Tijdschr Geneeskd (1993) 1.39
Reliable gastric tonometry after coronary artery surgery: need for acid secretion suppression despite transient failure of acid secretion. Intensive Care Med (1998) 1.38
[Unavoidable surgical intervention in two women with severe actinomycosis during IUD use]. Ned Tijdschr Geneeskd (2003) 1.38
Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis. Am J Med (1989) 1.34
A modified latex-fixation test for the detection of rheumatoid factors. J Clin Pathol (1979) 1.32
Inflammatory mediators in dengue virus infection in children: interleukin-8 and its relationship to neutrophil degranulation. Infect Immun (2000) 1.30
Prediction of microbial infection and mortality in medical patients with fever: plasma procalcitonin, neutrophilic elastase-alpha1-antitrypsin, and lactoferrin compared with clinical variables. Clin Infect Dis (1999) 1.26
Patterns of corticosteroid-binding globulin and the free cortisol index during septic shock and multitrauma. Intensive Care Med (2001) 1.26
Predictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus. Ann Rheum Dis (1986) 1.25
Proteolytic inactivation of plasma C1- inhibitor in sepsis. J Clin Invest (1989) 1.22
Peripheral vascular resistance in septic shock: its relation to outcome. Intensive Care Med (1988) 1.20
The differential effects of bacterial lipopolysaccharide (LPS) on splenic non-lymphoid cells demonstrated by monoclonal antibodies. Immunology (1986) 1.19
Interobserver variability in the use of APACHE II scores. Lancet (1999) 1.19
Macrophage migration inhibitory factor and hypothalamo-pituitary-adrenal function during critical illness. J Clin Endocrinol Metab (2001) 1.18
Inflammatory mediators in dengue virus infection in children: interleukin-6 and its relation to C-reactive protein and secretory phospholipase A2. Am J Trop Med Hyg (2001) 1.16
Gastrointestinal luminal PCO2 tonometry: an update on physiology, methodology and clinical applications. Br J Anaesth (2000) 1.15
Quantification of plasma factor XIIa-Cl(-)-inhibitor and kallikrein-Cl(-)-inhibitor complexes in sepsis. Blood (1988) 1.15
Reactivity of natural and induced human antibodies to MUC1 mucin with MUC1 peptides and n-acetylgalactosamine (GalNAc) peptides. Int J Cancer (2000) 1.15
APOE-epsilon4 is associated with memory decline in cognitively impaired elderly. Neurology (2000) 1.12
Humoral immune response to polymorphic epithelial mucin (MUC-1) in patients with benign and malignant breast tumours. Eur J Cancer (1996) 1.11
Accuracy and reliability of APACHE II scoring in two intensive care units Problems and pitfalls in the use of APACHE II and suggestions for improvement. Anaesthesia (2001) 1.10
[Corticosteroid administration for critically ill patients]. Ned Tijdschr Geneeskd (2001) 1.07
Systemic lupus erythematosus. II. Observations on the occurrence of exacerbations in the disease course: Dutch experience with 110 patients studied prospectively. Ann Rheum Dis (1989) 1.07
Polymorphic epithelial mucin (MUC-1)-containing circulating immune complexes in carcinoma patients. Br J Cancer (1995) 1.07
Hemodynamic determinants of mortality in human septic shock. Surgery (1986) 1.07
Frequencies of lipopolysaccharide core types in Escherichia coli strains from bacteraemic patients. Microbiology (1994) 1.06
Exercise induces gastric ischemia in healthy volunteers: a tonometry study. J Appl Physiol (1985) (2001) 1.06
Biventricular performance during volume loading in patients with early septic shock, with emphasis on the right ventricle: a combined hemodynamic and radionuclide study. Am Heart J (1988) 1.04
Plasma lipid peroxides and antioxidants in human septic shock. Intensive Care Med (1991) 1.04
Combination of flucloxacillin and gentamicin inhibits toxic shock syndrome toxin 1 production by Staphylococcus aureus in both logarithmic and stationary phases of growth. Antimicrob Agents Chemother (1997) 1.03
Derangements of coagulation and fibrinolysis in critically ill patients with sepsis and septic shock. Semin Thromb Hemost (1998) 1.03
International sepsis trial (INTERSEPT): role and impact of a clinical evaluation committee. Crit Care Med (1996) 1.02
Relative adrenal failure in intensive care: an identifiable problem requiring treatment? Best Pract Res Clin Endocrinol Metab (2001) 1.01
Heterologous double-determinant immunoradiometric assay CA 125 II: reliable second-generation immunoassay for determining CA 125 in serum. Clin Chem (1993) 1.01
Antibiotic-induced lipopolysaccharide (LPS) release from Salmonella typhi: delay between killing by ceftazidime and imipenem and release of LPS. Antimicrob Agents Chemother (1998) 1.01
Production and characterisation of mouse monoclonal antibodies reacting with the lipopolysaccharide core region of gram-negative bacilli. J Med Microbiol (1988) 1.00
In vivo effects of LPS on B lymphocyte subpopulations. Migration of marginal zone-lymphocytes and IgD-blast formation in the mouse spleen. Immunobiology (1985) 1.00
Serum tumor marker immunoassays in gynecologic oncology: establishment of reference values. Am J Obstet Gynecol (1996) 1.00
Systemic lupus erythematosus. I. Outcome and survival: Dutch experience with 110 patients studied prospectively. Ann Rheum Dis (1989) 1.00
Infusion of ultrafiltrate from endotoxemic pigs depresses myocardial performance in normal pigs. J Crit Care (1993) 0.99
Arginase release from red blood cells: possible link in transfusion induced immune suppression? Shock (2001) 0.99
alpha-atrial natriuretic peptide, cyclic guanosine monophosphate, and endothelin in plasma as markers of myocardial depression in human septic shock. Crit Care Med (2001) 0.99
CA 125: fundamental and clinical aspects. Semin Cancer Biol (1999) 0.98
Complement activation in patients with sepsis is in part mediated by C-reactive protein. J Infect Dis (1998) 0.98
Pathogenesis of renal failure in sepsis. Kidney Int Suppl (1998) 0.97
Endotoxin, cytokines, and procalcitonin in febrile patients admitted to the hospital: identification of subjects at high risk of mortality. Clin Infect Dis (2000) 0.96
Antibiotic-induced cell wall fragments of Staphylococcus aureus increase endothelial chemokine secretion and adhesiveness for granulocytes. Antimicrob Agents Chemother (1999) 0.96
Diagnostic ultrasound in clinical thyroid investigation. J Clin Endocrinol Metab (1971) 0.96
Decreased lysophosphatidylcholine/phosphatidylcholine ratio in cerebrospinal fluid in Alzheimer's disease. J Neural Transm (Vienna) (2003) 0.96
Blast cell leukaemia associated with IgA paraproteinaemia and Bence Jones protein. Br J Haematol (1970) 0.95
CA 125 serum levels in the early post-operative period do not reflect tumour reduction obtained by cytoreductive surgery. Eur J Cancer (1993) 0.95
Continuous infusion of lorazepam versus medazolam in patients in the intensive care unit: sedation with lorazepam is easier to manage and is more cost-effective. Crit Care Med (1999) 0.95
Systemic lupus erythematosus. III. Observations on clinical renal involvement and follow up of renal function: Dutch experience with 110 patients studied prospectively. Ann Rheum Dis (1989) 0.95
Predicting cardiac output responses to passive leg raising by a PEEP-induced increase in central venous pressure, in cardiac surgery patients. Br J Anaesth (2011) 0.95
The effects of sex steroids on plasma levels of marker proteins of endothelial cell functioning. Thromb Haemost (1998) 0.95
Prediction of shock in febrile medical patients with a clinical infection. Crit Care Med (2001) 0.94
An enzyme-linked immunosorbent assay for the measurement of circulating antibodies to polymorphic epithelial mucin (MUC1). Tumour Biol (1998) 0.94